Bristol Myers Squibb: This Pullback Is A Gift For Long-Term Investors (NYSE:BMY)
· seekingalpha.com
Buy Bristol Myers Squibb (BMY) on the dip: low 8.7x forward P/E, 4.6% yield, 9% sales growth and key H2 2026 readouts.
iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity f...